Hepatitis C, Chronic

"Hepatitis C, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Descriptor ID	D019698
MeSH Number(s)	C02.440.440.120 C02.782.350.350.120 C06.552.380.350.120 C06.552.380.705.440.120
Concept/Terms	Hepatitis C, Chronic Hepatitis C, Chronic Chronic Hepatitis C

Below are MeSH descriptors whose meaning is more general than "Hepatitis C, Chronic".

Diseases [C]
Virus Diseases [C02]
Hepatitis, Viral, Human [C02.440]
Hepatitis C [C02.440.440]
Hepatitis C, Chronic [C02.440.440.120]
RNA Virus Infections [C02.782]
Flaviviridae Infections [C02.782.350]
Hepatitis C [C02.782.350.350]
Hepatitis C, Chronic [C02.782.350.350.120]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatitis [C06.552.380]
Hepatitis, Chronic [C06.552.380.350]
Hepatitis C, Chronic [C06.552.380.350.120]
Hepatitis, Viral, Human [C06.552.380.705]
Hepatitis C [C06.552.380.705.440]
Hepatitis C, Chronic [C06.552.380.705.440.120]

Below are MeSH descriptors whose meaning is related to "Hepatitis C, Chronic".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C, Chronic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C, Chronic" by people in this website by year, and whether "Hepatitis C, Chronic" was a major or minor topic of these publications.

Bar chart showing 87 publications over 22 distinct years, with a maximum of 11 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2001	0	1	1
2002	3	0	3
2005	3	0	3
2006	2	0	2
2007	3	1	4
2008	5	0	5
2010	4	0	4
2011	2	0	2
2012	6	0	6
2013	8	2	10
2014	6	1	7
2015	11	0	11
2016	4	1	5
2017	2	2	4
2018	2	0	2
2019	5	0	5
2020	1	1	2
2021	5	0	5
2022	1	0	1
2023	3	0	3
2024	0	1	1

Below are the most recent publications written about "Hepatitis C, Chronic" by people in Profiles.

Sulkowski MS, Martinez A, Tyson GL, Scholz K, Franco RA, Kohli A, Julius SF, Deming P, Fink SA, Lynch K, Roytman M, Stainbrook TR, Turner MD, Viera-Briggs M, Ramers CB. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs. J Viral Hepat. 2024 06; 31(6):342-356.

View in: PubMed
Boudova S, Tholey D, Fenkel JM, Derman R, Boelig RC. Pregnancy as an Opportunity for Hepatitis C Virus Elimination and Eradication. Am J Trop Med Hyg. 2024 02 07; 110(2):199-201.

View in: PubMed
Kotani K, Enomoto M, Uchida-Kobayashi S, Tamori A, Yukawa-Muto Y, Odagiri N, Motoyama H, Kozuka R, Kawamura E, Hagihara A, Fujii H, Kageyama K, Yamamoto A, Yoshida A, Higashiyama S, Kawabe J, Kawada N. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis. J Gastroenterol. 2023 04; 58(4):394-404.

View in: PubMed
Beyoglu D, Schwalm S, Semmo N, Huwiler A, Idle JR. Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols. Int J Mol Sci. 2023 01 11; 24(2).

View in: PubMed
Cohen S, Cowan V, Rohan V, Pavlakis M, Curry MP, Adler JT, Safa K, Fleishman A, Shenkel J, Rodrigue JR. Willingness of Kidney and Liver Transplant Candidates to Receive HCV-Infected Organs. J Surg Res. 2022 10; 278:342-349.

View in: PubMed
Freidel MR, Armen RS. Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein. J Chem Inf Model. 2021 12 27; 61(12):5906-5922.

View in: PubMed
Lai CW, Nishio A, Hasan S, Kefalakes H, Rehermann B, Ghany MG. Spontaneous Clearance of Drug-Resistant Chronic Hepatitis C Virus Infection. Hepatology. 2021 12; 74(6):3552-3553.

View in: PubMed
Azhar A, Binari LA, Joglekar K, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Hall IE, Rofaiel G, Forbes RC, Shaffer D, Concepcion BP, Molnar MZ. Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys. Clin Transplant. 2021 12; 35(12):e14485.

View in: PubMed
Goldstein ND, Kahal D, Testa K, Burstyn I. Inverse probability weighting for selection bias in a Delaware community health center electronic medical record study of community deprivation and hepatitis C prevalence. Ann Epidemiol. 2021 08; 60:1-7.

View in: PubMed
M?llhaupt B, Semela D, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Negro F, Semmo N. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Med Wkly. 2021 01 18; 151:w20399.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement